Quick Order Cart

Cat. No. ARG34435

KPNA3 Knockout jurkat Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Blood (peripheral blood)

  • Disease:

    Acute lymphoblastic leukemia (ALL)

The KPNA3 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from Jurkat T lymphocytes, with disruption of the KPNA3 gene encoding importin alpha-3. This importin adaptor recognizes classical NLS motifs on cargoes including NF-kappaB p65 and NFAT, linking them to importin beta-1 for nuclear translocation. The knockout blocks nuclear import of these transcription factors, attenuating TCR- and cytokine-driven gene expression. The model facilitates investigation of nuclear transport dynamics, importin alpha isoform specialization, and NF-kappaB/NFAT transcriptional regulation, supporting applications in immunology, leukemia research, and nuclear import inhibitor screening.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Jurkat

    Cell Type

    T cell line

    Sex of Donor

    Male

    Age

    14 years

    Derived From Site

    In situ; Peripheral blood

    Gene Name

    KPNA3

    Gene Identifier

    NCBI Gene ID 3839

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KPNA3 Knockout Jurkat Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Jurkat T lymphocyte line, in which the KPNA3 gene has been disrupted. This polyclonal pool contains a heterogeneous mix of genetically modified cells, minimizing clonal bias and offering a broad loss-of-function platform for dissecting importin alpha-3 biology. The absence of single-cell cloning ensures that the population retains diverse editing events, providing a more representative model for functional investigations.

The parental Jurkat cell line is an immortalized T lymphoblastoid line, originally derived from the peripheral blood of a 14-year-old male with acute T cell leukemia. As a leukemic T cell model, Jurkat cells are instrumental in research on T cell receptor (TCR) signaling, programmed cell death, and viral infections such as HIV. The widely utilized Jurkat E6-1 clone preserves essential T-cell signaling machinery, making it a well-validated host for studying signal transduction pathways and immune responses.

KPNA3 encodes importin subunit alpha-3, a critical nuclear transport adaptor that recognizes classical nuclear localization signals (NLS) on cargo proteins, linking them to importin beta-1 (KPNB1) for translocation through the nuclear pore complex. This adaptor directly interacts with NLS-bearing transcription factors like NF-kappaB p65 and NFAT, and associates with nucleoporins NUP50 and NUP62 during transport. KPNA3 activity is modulated by upstream signals from TCR activation, interferon-gamma, and NF-kappaB, and it governs the nuclear accumulation of downstream effectors including NF-kappaB p65, NFAT, STAT1, and IRF3. Consequently, KPNA3 serves as a key regulatory node coordinating extracellular stimuli with nuclear gene expression programs in T cells.

In Jurkat T cells, KPNA3 gene disruption specifically hinders the nuclear import of essential immune transcription factors, thereby impairing TCR-induced and cytokine-driven transcriptional responses. This polyclonal knockout model permits researchers to discriminate importin alpha isoform-specific functions in T cell activation, survival signaling, and leukemogenesis, as the nuclear accumulation of transcription factors such as NF-kappaB and NFAT is required for activation marker expression and pro-survival gene induction. The model further enables the study of leukemia cell vulnerabilities linked to nuclear transport dependencies.

This cell population is suitable for a range of applications, including mechanistic studies of nuclear transport, functional specialization among importin alpha isoforms, and transcriptional regulation by NF-kappaB and NFAT. Researchers can employ this model in subcellular fractionation western blotting, immunofluorescence localization of transcription factors, flow cytometric detection of CD69 and CD25, NF-kappaB luciferase reporter assays, RT-qPCR gene expression analysis, and co-immunoprecipitation of KPNA3-cargo complexes. The polyclonal nature also supports high-throughput screening for nuclear import inhibitors. For further information or technical assistance, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)